Tumour necrosis factor-α levels are elevated in adolescent patients with juvenile idiopathic arthritis on etanercept therapy

Eitemau Tebyg

• Association of Anxiety With Pain and Disability but Not With Increased Measures of Inflammation in Adolescent Patients With Juvenile Idiopathic Arthritis
  gan: Hanns, Laura, et al.
  Cyhoeddwyd: (2020)
• Circulating complexes between tumour necrosis factor‐alpha and etanercept predict long‐term efficacy of etanercept in juvenile idiopathic arthritis
  gan: Kahn, Robin, et al.
  Cyhoeddwyd: (2016)
• Juvenile arthritis disease activity score is a better reflector of active disease than the disease activity score 28 in adults with polyarticular juvenile idiopathic arthritis
  gan: Wu, Qiong, et al.
  Cyhoeddwyd: (2016)
• Etanercept in juvenile idiopathic arthritis: Who will benefit?
  gan: van den Berg JM, et al.
  Cyhoeddwyd: (2011-09-01)
• Challenges in the management of juvenile idiopathic arthritis with etanercept
  gan: Pain, Clare E, et al.
  Cyhoeddwyd: (2009)